A.N. SAMOYLOV¹, A.N. KOROBITSIN²

¹Kazan State Medical University, 49 Butlerov St., Kazan, Russian Federation, 420012

²Republican Clinical Ophthalmology Hospital of the Ministry of Health Care of the Republic of Tatarstan, 14 Butlerov St., Kazan, Russian Federation, 420012

Samoylov A.N. ― D. Med. Sc., Professor, Head of the Ophthalmology Department, tel. (843) 238-95-93, e-mail: [email protected]

Korobitsin A.N. ― ophthalmologist, tel. (843) 238-95-93, e-mail: [email protected]

The article shows the diagnostic value of the method of determining the retinal visual acuity in predicting the combined operative treatment in patients with pathological myopia. The applied method of treatment resulted in a higher visual acuity compared with preoperative data.

Key words: high myopia, pathological myopia, retinal visual acuity, macular vitreomacular traction syndrome, vitrectomy.

1. Pizzarello L., Abiose A. et al. VISION 2020: The Right to Sight: a global initiative to eliminate avoidable blindness // Arch. Ophthalmol. ― 2004. ― 122. ― 615-620.
2. Kempen J.H., Mitchell P., Lee K.E. et al. The prevalence of refractive errors among adults in the United States, Western Europe, and Australia // Ophthalmol. ― 2004. ― Apr. ― 122 (4). ― P. 495-505.
3. Avila M.P., Weiter J.J., Jalkh A.E. et al. Natural history of choroidal neovascularization in degenerative myopia // Ophthalmology. ― 1984. ― Vol. 91. ― P. 1573-81.
4. Soubrane G. Choroidal neovascularization in pathologic myopia: recent developments in diagnosis and treatment // Survey of ophthalmology. ― 2008. ― №2. ― P. 121-136.
5. Blinder K.J., Blumenkranz M.S., Bressler N.M. et al. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial-VIP report no. 3 // Ophthalmology. ― 2003. ― Vol. 110. ― P. 667-73.
6. Muller B., Joussen A. // Klin. Monbl Augen. ― 2011. ― Sep. ― 228. ― P. 771-9.